木瓜直播

Elizabeth Hlavinka

Elizabeth Hlavinka

Authors >

Elizabeth Hlavinka

Elizabeth Hlavinka covers psychiatry and pediatric news for 木瓜直播, where she is also a member of the Enterprise & Investigative Reporting team and a producer on the Anamnesis podcast. Before joining 木瓜直播 in 2018, she covered arts and culture for several publications in Texas. She is particularly interested in covering stories related to the U.S.-Mexico border, women's health, and mental health. She is based in New York City, where you can most likely find her cruising around on her bike when she鈥檚 not writing.

Connect:

email image

Latest from Elizabeth Hlavinka

AAN over an image of the Pennsylvania Convention Center.

Mixed Results with Tranexamic Acid in TBI

No benefit for neurological outcomes; some improvement in 28-day mortality rate

A woman is laying in bed and looking solemnly at a bunch of pill bottles.

Detailed Policy Cuts Opioid Use After Breast Ca Surgery

40% of women reported zero narcotic use after surgery

AAN over an image of the Pennsylvania Convention Center.

Calcium Channel Blocker Flops in Parkinson's Disease Trial

"Disappointing" results from 3-year study don't back prior findings

The letters PAS over a pic of the Baltimore convention center.

Secondhand Smoke May Set Kids Up for Hypertension

Researchers measure link between tobacco-specific nitrosamine and higher blood pressure

PES over a photo of the Baltimore Convention Center.

Weekly hGH Shows Promise for Youth GH Deficiency

Two trials demonstrate weekly formation is at least as efficacious as once-daily

The letters PES over a pic of the Baltimore convention center.

ADHD Tied to Short Stature in Early Childhood

Longer ADHD medication use also associated with lower height-for-age z scores

Ups and Downs of Exercise for Women's Bone Health

Uphill versus downhill treadmill walking makes a difference in trial

Suppressed Testicular Function 'Mostly Reversible' After Steroid Abuse

But process can take upwards of 9 months

HIV Exposure in Womb Tied to Metabolic Disease in Later Life

Upped risk for immune dysfunction as well, possibly due to inflammation

Oral Semaglutide Tops Sitagliptin for Cutting HbA1c, Weight in T2D

Positive results from PIONEER 3 trial in diabetic patients who aren't responding to metformin with or without sulfonylurea

鈥�

10

鈥�